Market capitalization | $1.35b |
Enterprise Value | $1.31b |
P/E (TTM) P/E ratio | 37.34 |
EV/FCF (TTM) EV/FCF | 25.23 |
EV/Sales (TTM) EV/Sales | 0.58 |
P/S ratio (TTM) P/S ratio | 0.60 |
P/B ratio (TTM) P/B ratio | 1.78 |
Revenue growth (TTM) Revenue growth | 54.81% |
Revenue (TTM) Revenue | $2.25b |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
12 Analysts have issued a Astrana Health forecast:
12 Analysts have issued a Astrana Health forecast:
Mar '25 |
+/-
%
|
||
Revenue | 2,251 2,251 |
55%
55%
|
|
Gross Profit | 239 239 |
7%
7%
|
|
EBITDA | 109 109 |
1%
1%
|
EBIT (Operating Income) EBIT | 80 80 |
14%
14%
|
Net Profit | 35 35 |
44%
44%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam on November 1, 1985 and is headquartered in Alhambra, CA.
Head office | United States |
CEO | Brandon Sim |
Employees | 1,900 |
Founded | 1985 |
Website | www.astranahealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.